Transcriptional regulation of NK cell state by ELF4 links innate immune licensing to kidney fibrosis

Fibrosis is a common outcome of chronic tissue injury, yet immune regulators that are conserved across species and translatable to human disease remain poorly defined. By integrating human kidney transcriptomes with multiple murine models of kidney fibrosis, we identified the ETS transcription factor ELF4 as a conserved, immune-enriched regulator associated with disease severity. ELF4 expression was highest in natural killer (NK) cells. Genetic deletion of Elf4, including NK cell-specific ablation, attenuated experimental kidney injury, with reduced inflammation, fibrosis, and loss of renal function. Single-cell and functional analyses showed that ELF4 deficiency disrupts late-stage NK cell maturation and broadly suppresses cytotoxic and interferon-γ (IFNγ) effector programs. Mechanistically, ELF4 directly sustains STAT1 transcription, maintaining a STAT1-TBX21 program required for NK cell maturation and effector competence. Consistent with this framework, NK cell depletion, IFNγ neutralization, or antisense-mediated suppression of Elf4 phenocopied renal protection. Together, these findings identify ELF4 as a transcriptional licensing factor that links NK cell state to kidney injury and highlight innate immune programming as a potential therapeutic entry point in chronic kidney disease.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Investigation
Published
2026-11-12
DOI
https://doi.org/10.1172/jci208155
Primary Topic
Immune Cell Function and Interaction
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Transcriptional regulation of NK cell state by ELF4 links innate immune licensing to kidney fibrosis

Christopher A. Hunter, Elisa Cruz-Morales, Éric Vivier, Zachary R. Lanzar et al.
Journal of Clinical Investigation
Immune Cell Function and Interaction
article

Transcriptional regulation of NK cell state by ELF4 links innate immune licensing to kidney fibrosis

Christopher A. Hunter, Elisa Cruz-Morales, Éric Vivier, Zachary R. Lanzar, Lin Meei‐Hua, Rojesh Shrestha, Hongbo Liu, Hailong Hu, Katalin Suszták, Carrie L. Lucas, Aaron Joseph Donner, Andrea Sánchez‐Navarro, Marco Ruella, Audrey C. Bochi-Layec, Shen Li, Jeffrey H. Miner, Thomas A. Bell, Xiangchen Gu, Jihwan Park
article en

Abstract

Fibrosis is a common outcome of chronic tissue injury, yet immune regulators that are conserved across species and translatable to human disease remain poorly defined. By integrating human kidney transcriptomes with multiple murine models of kidney fibrosis, we identified the ETS transcription factor ELF4 as a conserved, immune-enriched regulator associated with disease severity. ELF4 expression was highest in natural killer (NK) cells. Genetic deletion of Elf4, including NK cell-specific ablation, attenuated experimental kidney injury, with reduced inflammation, fibrosis, and loss of renal function. Single-cell and functional analyses showed that ELF4 deficiency disrupts late-stage NK cell maturation and broadly suppresses cytotoxic and interferon-γ (IFNγ) effector programs. Mechanistically, ELF4 directly sustains STAT1 transcription, maintaining a STAT1-TBX21 program required for NK cell maturation and effector competence. Consistent with this framework, NK cell depletion, IFNγ neutralization, or antisense-mediated suppression of Elf4 phenocopied renal protection. Together, these findings identify ELF4 as a transcriptional licensing factor that links NK cell state to kidney injury and highlight innate immune programming as a potential therapeutic entry point in chronic kidney disease.

Journal of Clinical Investigation
Centre National de la Recherche Scientifique (FR), Inserm (FR), Washington University in St. Louis (US), Aix-Marseille Université (FR), Ionis Pharmaceuticals (United States) (US), Yale University (US), Centre d’Immunologie de Marseille-Luminy (FR), University of Pennsylvania (US)
National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
Good health and well-being
Immune Cell Function and Interaction
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon